Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/10/2012WO2012060431A1 Patch
05/10/2012WO2012060376A1 Felbinac-containing external patch
05/10/2012WO2012059937A1 Modifies release pharmaceutical compositons for nsaids
05/10/2012WO2012059936A1 Pharmaceutical compositions for colloidal drug delivery
05/10/2012WO2012059815A1 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
05/10/2012WO2012059724A1 Formulations comprising polyethylene glycol
05/10/2012WO2012059693A1 Marked solid pharmaceutical form, and method for the production thereof by means of laser marking
05/10/2012WO2012059515A1 Kit for the localized activation of high concentrations of a drug and the procedure thereof
05/10/2012WO2012059447A1 A composition comprising s-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium
05/10/2012WO2012059338A1 Sustained-release tablet and process for preparing the same
05/10/2012WO2012059014A1 Chinese medicine hair-regrowth preparation and formula and preparation method therefor
05/10/2012WO2012058849A1 Extract of fermented hirsutella sinensis powder, preparing method and use in manufacturing medicaments for preventing and treating renal failure
05/10/2012WO2012058826A1 Medicine for treating psoriasis
05/10/2012WO2012058795A1 Uses of unsaturated fatty acids for inhibiting virus replication and /or infection
05/10/2012WO2012035429A3 Remotely controlled drug delivery systems
05/10/2012WO2012026711A3 Composite powder of titanium dioxide and mica, and makeup cosmetic composition containing same
05/10/2012WO2012024634A3 Environmentally-responsive nanocomposites and methods of their use
05/10/2012WO2012022919A3 Nalbuphine-based formulations and uses thereof
05/10/2012WO2012018383A3 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof
05/10/2012WO2012018380A3 Compositions and methods for inducing immune tolerance
05/10/2012WO2012018377A3 Liposome targeting compounds and related uses
05/10/2012WO2012017325A3 Apparatus and process for encapsulating microparticles with liquid in soft gel capsules
05/10/2012WO2012016181A3 Anti-allergy lozenges
05/10/2012WO2012012347A3 Methods of intravenous administration of glyburide and other drugs
05/10/2012WO2012010977A8 Single daily dosage form for prevention and treatment of metabolic syndrome
05/10/2012WO2012006612A3 Use of trans-palmitoleate in identifying and treating metabolic disease
05/10/2012WO2011149875A3 Method of filling an intraluminal reservoir with a therapeutic substance
05/10/2012WO2011146589A3 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
05/10/2012WO2011139486A3 Layered drug delivery device
05/10/2012WO2011130462A3 Intraocular pressure reduction with intracameral bimatoprost implants
05/10/2012WO2011128635A3 Anti-abuse pharmaceutical compositions
05/10/2012WO2011128631A3 Vegetarian oral pharmaceutical and nutraceutical compositions
05/10/2012WO2011127244A3 ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
05/10/2012WO2011124876A3 A freeze-dried tablet
05/10/2012WO2011120904A3 A fast dissolving pharmaceutical composition
05/10/2012WO2011116286A4 Stable bortezomib formulations
05/10/2012WO2011112875A3 Foamable formulation
05/10/2012WO2011109415A3 Reducing viscosity of pharmaceutical formulations
05/10/2012WO2011100975A3 Stabilized tacrolimus composition
05/10/2012WO2011067673A3 Circulation of components during microfluidization and/or homogenization emulsions
05/10/2012WO2011064271A4 Use of an oleo gel containing triterpene for healing wounds
05/10/2012WO2011022460A8 Novel cationic lipids with various head groups for oligonucleotide delivery
05/10/2012WO2010144789A3 Diketopiperazine microparticles with defined specific surface areas
05/10/2012US20120116481 System and Apparatus for Controlled Activation of Acute Use Medical Devices
05/10/2012US20120116215 Deployment of polysaccharide markers for treating a site within a patient
05/10/2012US20120115957 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/10/2012US20120115787 Sclerostin and the inhibition of WNT signaling and bone formation
05/10/2012US20120114831 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114758 Beverage for pregnancy & lactation
05/10/2012US20120114757 Particles comprising drospirenone encapsulated in a polymer
05/10/2012US20120114756 Sustained-release drug carrier composition
05/10/2012US20120114755 Methods and materials for tissue repair
05/10/2012US20120114754 Rapidly disintegrating solid oral dosage form
05/10/2012US20120114753 Multi-layer tablet comprising effervescent layer
05/10/2012US20120114752 Stable tablet containing 4,5-epoxymorphinan derivative
05/10/2012US20120114751 Pharmaceutical composition for treating hcv infections
05/10/2012US20120114750 Pharmaceutical composition 271
05/10/2012US20120114749 Compositions and methods for delivery of embolics
05/10/2012US20120114748 Tanaproget Compositions Containing Ethinyl Estradiol
05/10/2012US20120114747 Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
05/10/2012US20120114746 Immunostimulatory Compositions Comprising Liposome-Encapsulated Oligonucleotides and Epitopes
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114744 Compositions and methods to treat muscular & cardiovascular disorders
05/10/2012US20120114743 Transdermal ricinoleic acid compositions
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114741 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
05/10/2012US20120114740 Sustained release formulation of a non-steroidal anti-inflammatory drug
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120114738 Transdermal patch
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114735 Compositions and methods for the treatment of throat discomfort
05/10/2012US20120114734 Nanostructure surface coated medical implants and methods of using the same
05/10/2012US20120114732 Elastin stabilization of connective tissue
05/10/2012US20120114731 Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
05/10/2012US20120114730 Compositions and methods for treating precocious puberty
05/10/2012US20120114729 Silicone-peroxide compositions for long-term, controlled oxygen release
05/10/2012US20120114717 Tableting agent having a low water content, and method for the production thereof
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114715 Use of larch wood for treating inflammation
05/10/2012US20120114714 Method for the treatment and prevention of erectile dysfunction
05/10/2012US20120114713 Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease
05/10/2012US20120114712 Umbilical cord biomaterial for medical use
05/10/2012US20120114711 Pharmaceutical composition having improved solubility
05/10/2012US20120114710 Carbon nanotubes complexed with multiple bioactive agents and methods related thereto
05/10/2012US20120114709 Formulations for use in inhaler devices
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114707 Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114705 Water soluble film for oral administration with instant wettability
05/10/2012US20120114704 Compounds, compositions and methods of treating cancer and fibrotic diseases
05/10/2012US20120114703 Botulinum Toxin Administration to Treat Various Conditions
05/10/2012US20120114702 Compositions and methods for treating asthma and other lung disorders
05/10/2012US20120114692 Immunogenic compositions containing phospholipid
05/10/2012US20120114566 Lipoxin analogs and methods for the treatment of periodontal disease
05/10/2012US20120114559 Nanoimprint lithography formation of functional nanoparticles using dual release layers
05/10/2012US20120114547 Stabilization and ionic triggering of nitric oxide release
05/10/2012US20120111743 Binary foaming cleaner and disinfectant solution
05/10/2012US20120111324 Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore
05/10/2012DE102010043733A1 Unbeladene PEGylierte Liposomen zur Verwendung als Arzneimittel zur Prophylaxe und Therapie von hämorrhagischen und thrombo- embolischen Erkrankungen Unloaded PEGylated liposomes for use as a medicament for the prophylaxis and treatment of hemorrhagic and thromboembolic disorders
1 ... 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 ... 2991